Pseudomonas Exotoxin A Based Toxins Targeting Epidermal Growth Factor Receptor for the Treatment of Prostate Cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pseudomonas Exotoxin A Based Toxins Targeting Epidermal Growth Factor Receptor for the Treatment of Prostate Cancer
Authors
Keywords
-
Journal
Toxins
Volume 12, Issue 12, Pages 753
Publisher
MDPI AG
Online
2020-11-30
DOI
10.3390/toxins12120753
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Revisiting Immunotherapy: A Focus on Prostate Cancer
- (2020) Ha-Ram Cha et al. CANCER RESEARCH
- Photochemical Internalization for Intracellular Drug Delivery. From Basic Mechanisms to Clinical Research
- (2020) Waseem Jerjes et al. Journal of Clinical Medicine
- Impact of the endosomal escape activity of cell-penetrating peptides on the endocytic pathway
- (2020) Helena M. Kondow-McConaghy et al. ACS Chemical Biology
- Immunogenicity of Immunotoxins Containing Pseudomonas Exotoxin A: Causes, Consequences, and Mitigation
- (2020) Ronit Mazor et al. Frontiers in Immunology
- Immunotherapy in Prostate Cancer
- (2020) Emily K. Fay et al. Cancers
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- New Prostate Cancer Targets for Diagnosis, Imaging, and Therapy: Focus on Prostate-Specific Membrane Antigen
- (2018) Alessia Cimadamore et al. Frontiers in Oncology
- The Diagnosis and Treatment of Prostate Cancer
- (2017) Mark S. Litwin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways
- (2017) et al. Cancers
- HER2 and EGFR Overexpression Support Metastatic Progression of Prostate Cancer to Bone
- (2016) Kathleen C. Day et al. CANCER RESEARCH
- Immunogenicity of therapeutic recombinant immunotoxins
- (2016) Ronit Mazor et al. IMMUNOLOGICAL REVIEWS
- In vitro and in vivo effects of a recombinant anti-PSMA immunotoxin in combination with docetaxel against prostate cancer
- (2016) Marta Michalska et al. Oncotarget
- Immunotoxin Therapies for the Treatment of Epidermal Growth Factor Receptor-Dependent Cancers
- (2016) Nathan Simon et al. Toxins
- Augmenting the Efficacy of Immunotoxins and Other Targeted Protein Toxins by Endosomal Escape Enhancers
- (2016) Hendrik Fuchs et al. Toxins
- EGF Receptor Promotes Prostate Cancer Bone Metastasis by Downregulating miR-1 and Activating TWIST1
- (2015) Y.-S. Chang et al. CANCER RESEARCH
- Novel EGFR-specific immunotoxins based on panitumumab and cetuximab show in vitro and ex vivo activity against different tumor entities
- (2015) Judith Niesen et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Pseudomonas Exotoxin A: optimized by evolution for effective killing
- (2015) Marta Michalska et al. Frontiers in Microbiology
- EGFR mediates docetaxel resistance in human castration-resistant prostate cancer through the Akt-dependent expression of ABCB1 (MDR1)
- (2014) Tzyh-Chyuan Hour et al. ARCHIVES OF TOXICOLOGY
- Prostate stem cell antigen and cancer risk, mechanisms and therapeutic implications
- (2013) Xueling Yang et al. Expert Review of Anticancer Therapy
- Efficacy of Cetuximab in Metastatic Castration-Resistant Prostate Cancer Might Depend on EGFR and PTEN Expression: Results from a Phase II Trial (SAKK 08/07)
- (2012) R. Cathomas et al. CLINICAL CANCER RESEARCH
- Recombinant immunotoxin engineered for low immunogenicity and antigenicity by identifying and silencing human B-cell epitopes
- (2012) W. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Preclinical Evaluation of a Recombinant Anti-Prostate Specific Membrane Antigen Single-Chain Immunotoxin Against Prostate Cancer
- (2010) Philipp Wolf et al. JOURNAL OF IMMUNOTHERAPY
- Molecular alterations of EGFR and PTEN in prostate cancer: association with high-grade and advanced-stage carcinomas
- (2010) Silvia de Muga et al. MODERN PATHOLOGY
- A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Vandetanib Plus Docetaxel/Prednisolone in Patients with Hormone-Refractory Prostate Cancer
- (2009) József Horti et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Novel targeted therapeutics for metastatic castration-resistant prostate cancer
- (2009) Emmanuel S. Antonarakis et al. CANCER LETTERS
- Targeted Therapies for Prostate Cancer Against the Prostate Specific Membrane Antigen
- (2009) U. Elsasser-Beile et al. CURRENT DRUG TARGETS
- EGFR ligand switch in late stage prostate cancer contributes to changes in cell signaling and bone remodeling
- (2009) Alyse M. DeHaan et al. PROSTATE
- Results from a monocentric phase II trial of erlotinib in patients with metastatic prostate cancer
- (2008) G. Gravis et al. ANNALS OF ONCOLOGY
- Structure-Based View of Epidermal Growth Factor Receptor Regulation
- (2008) Kathryn M. Ferguson Annual Review of Biophysics
- EGFR family: Structure physiology signalling and therapeutic targets†
- (2008) Antony W. Burgess GROWTH FACTORS
- Pseudomonas exotoxin A: From virulence factor to anti-cancer agent
- (2008) Philipp Wolf et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now